ARID1A and breast carcinoma: Our observation is in agreement with a series of studies revealing that ARID1A expression is frequently lost or reduced in a number of cancer tissues and cell lines, such as breast cancer, uterine endometrioid carcinoma, ovarian clear cell and endometrioid carcinoma [13,18,20, and 21].